WHAT IS ALREADY KNOWN ON THIS TOPIC Accumulating evidence indicates that elevated inflammation may play a causal role in the development of post-traumatic stress disorder (PTSD) symptoms, and in PTSD-related increased risk for cardiovascular, autoimmune and neurodegenerative diseases.
▸ PTSD and depression are highly comorbid and in fact, patients who meet criteria for severe PTSD also typically meet criteria for major depression. Thus, although the authors attempt to do so here, it is difficult to understand the association between PTSD and inflammation independent of depression. Very large studies including people with and without PTSD and with and without depression will be needed to clarify. ▸ For sIL-2R, sIL-6R and IFN-γ, results were based on only two studies each, yielding small sample sizes ranging from 22 to 79 patients with PTSD.
WHAT NEXT IN RESEARCH
This meta-analysis raises important questions for future research. First, results highlighted that levels of some but not all inflammatory markers are increased in PTSD. Future research should focus on uncovering the precise transcriptional control mechanisms underlying elevated inflammation in PTSD, as in prior small studies. 3 Anti-inflammatory treatments for psychiatric disorders will need to be highly targeted at specific transcriptional control pathways because inflammation plays a critical role across bodily systems. Second, it is clear that not all individuals with PTSD show elevated inflammation. Given the multitude of symptom combinations that can underlie PTSD, 4 it will be important to identify if only some subtypes of PTSD are associated with elevated inflammation. For example, perhaps only individuals with higher levels of threat sensitivity will show elevated inflammation. 2 Finally, the field must uncover causal mechanisms of the relationship between inflammation and PTSD, possibly using targeted antiinflammatory agents in randomised clinical trials.
DO THESE RESULTS CHANGE YOUR PRACTICES AND WHY?
No. Even though the present study provides the strongest evidence to date that inflammation is elevated in PTSD, these results are unlikely to have an immediate impact on clinical practice. It remains premature to prescribe anti-inflammatory treatments for patients with PTSD because we do not know which treatments would be beneficial, nor for whom. However, reducing inflammation is another reason to recommend and facilitate a healthy lifestyle in patients with PTSD, particularly with regard to sleep, physical activity and diet. 5 Twitter Follow Aoife O'Donovan at @thethrivelab
